Advertisement

Radical radiotherapy for superficial esophageal cancer: impact of clinical N stage on survival.

09:51 EDT 18th May 2013 | BioPortfolio

Summary of "Radical radiotherapy for superficial esophageal cancer: impact of clinical N stage on survival."

Aim: To retrospectively analyze the results of radical radiotherapy for patients with superficial esophageal cancer (SEC).

Affiliation

Department of Radiation Oncology, Osaka University, 2-2 (D10) Yamadaoka, Suita, Osaka, 565-0871, Japan. kogawa@radonc.med.osaka-u.ac.jp.

Journal Details

This article was published in the following journal.

Name: Anticancer research
ISSN: 1791-7530
Pages: 3371-6

Links

Medical and Biotech [MESH] Definitions

Radiotherapy, Adjuvant

Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.

National Cancer Institute (u.s.)

Component of the NATIONAL INSTITUTES OF HEALTH. Through basic and clinical biomedical research and training, it conducts and supports research with the objective of cancer prevention, early stage identification and elimination. This Institute was established in 1937.

Esophageal Neoplasms

Tumors or cancer of the ESOPHAGUS.

Radiotherapy Dosage

The total amount of radiation absorbed by tissues as a result of radiotherapy.

Hydroxyl Radical

The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.

PubMed Articles [ 35827 Associated PubMed Articles listed on BioPortfolio]

Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer.

BACKGROUND: The aim of this study was to assess the long-term outcomes of combining high-dose-rate intraluminal brachytherapy (IBT) with external beam radiotherapy (EBRT) for superficial esophageal ca...

Prognostic factors in definitive radiochemotherapy of advanced inoperable esophageal cancer.

The aim of this study was to assess the efficacy and prognostic factors of definitive radiochemotherapy (RCT) for inoperable esophageal cancer. Between 1995 and 2005 all patients with inoperable esoph...

Technological advances in radiotherapy for esophageal cancer.

Radiotherapy with concurrent chemotherapy and surgery represent the main treatment modalities in esophageal cancer. The goal of modern radiotherapy approaches, based on recent technological advances,...

New invasive patterns as a prognostic factor for superficial esophageal cancer.

BACKGROUND: Prognostic factors for superficial esophageal cancer cannot be limited to such factors as lymph node metastasis (N factor), depth of tumor invasion (T factor), and genetic alterations. The...

Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: Routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.

Background. The prevalence of esophageal cancer accompanied by hypopharyngeal cancer (HPC) is high and increasing rapidly in Asia. The purpose of this prospective study was to evaluate the prevalence...

Clinical Trials [ 6532 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator

To evaluate the clinical impact of an online video simulator during the learning period of laparoscopic radical prostatectomy.

A Study for Treatment of Superficial Bladder Cancer Using OGX-427

This is a single centre, open label, phase I dose escalation trial using a modified accelerated titration design. Patients with superficial bladder tumour (Ta or T1) or CIS and candidates...

Positron Emission Tomography in Determining Stage of Esophageal Cancer

RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer. PURPOSE: This clinical trial is studying how well f...

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

RATIONALE: Photodynamic therapy uses a drug, such as HPPH, that is absorbed by tumor cells. The drug becomes active when it is exposed to light, and kills tumor cells. HPPH may be effectiv...

FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer

This phase II trial is studying the effects of oxaliplatin, leucovorin and fluorouracil-when given together with Cetuximab and radiation therapy and radiation therapy to see how they work...

Search BioPortfolio: